Irish Journal of Medical Science

, Volume 172, Issue 4, pp 168–170 | Cite as

Target blood pressure for patients with type 2 diabetes is difficult to achieve in the setting of a busy diabetes clinic

original paper


Background Target blood pressure control in patients with type 2 diabetes should be 130/85mmHg or less; however, it is not clear how achievable this target is in clinical practice.

Aim To assess the adequacy of blood pressure control in patients with type 2 diabetes attending a busy outpatient clinic.

Methods One hundred and eight patients with type 2 diabetes were assessed for the presence of hypertension using a cut-off value of 130/85mmHg. Antihypertensive treatment and diabetic complications were evaluated.

Results Hypertension was present in 67% of patients, in whom 90% were receiving anti-hypertensive treatment.. Forty-nine per cent of the treated patients achieved target blood pressure. Of the undertreated patients, 55% were on one antihypertensive agent, 30% were on two agents and 15% were on three or more agents. The corresponding figures for the adequately treated patients were 28%, 31% and 41%, respectively (p=0.03).

Conclusion Adequate blood pressure control was underachieved in this patient group underlying the difficulty in treating blood pressure to target values in patients with type 2 diabetes in the setting of outpatient diabetes clinics. A more aggressive strategy, in particular the use of multiple antihypertensive agents should be adopted.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study.Diabetes Care 1979; 2: 120–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality in men screened in the Multiple Risk Factor Intervention Trial.Diabetes Care 1993; 16: 434–44.PubMedCrossRefGoogle Scholar
  3. 3.
    Hansson L, Zanchetti A, Carruthers SG et al. For the HOT study group. Effect of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial.Lancet 1998; 351: 1755- 62.PubMedCrossRefGoogle Scholar
  4. 4.
    The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.Arch Intern Med 1997; 157: 2413–46.CrossRefGoogle Scholar
  5. 5.
    Ramsay LE, Williams B, Johnston GD et al. For the British Hypertensive Society. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.J Hum Hypertens 1999; 13: 569–92.PubMedCrossRefGoogle Scholar
  6. 6.
    ADA Position Statement. Treatment of hypertension in adults with diabetes.Diabetes Care 2002; 25 (suppl 1): S71–3.Google Scholar
  7. 7.
    Toumilehto J, Rastenyte D, Birkenhager WH et al. For the systolic hypertension in €pe trial investigators. Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension.N Engl J Med 1999; 340: 677–84.CrossRefGoogle Scholar
  8. 8.
    UK Prospective Diabetes Study Group. Tight blood pressure and risk of microvascular and macrovascular complications in type 2 diabetes: UKPDS 38.BMJ 1998; 317: 703–13.Google Scholar
  9. 9.
    Deedwania PC. Hypertension and diabetes, new therapeutic options.Arch Intern Med 2000; 160: 1585–94.PubMedCrossRefGoogle Scholar
  10. 10.
    George BP, Tobin KJ, Corpus RA, Devlin WH, O’Neil WW. Treatment of cardiovascular risk factors in diabetic patients: How well do we follow the guidelines.Am Heart J 2001; 142: 857–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Lazarus JM, Bourgoiqnie JJ, Buckalew VM et al. For the modification of diet in renal disease study group. Achievement and safety of a low blood pressure goal in chronic renal disease.Hypertension 1997; 29: 641–50.PubMedGoogle Scholar
  12. 12.
    Mancia G, Zanchetti A. White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?J Hypertens 1995; 9: 1049–52.Google Scholar

Copyright information

© Springer London 2003

Authors and Affiliations

  1. 1.Department of Endocrinology and Diabetes MellitusJames Connolly Memorial HospitalDublinIreland
  2. 2.Department of EndocrinologyDDC, Beaumont HospitalDublin 9Ireland

Personalised recommendations